Komori
Mitani Sangyo (8285) · InitiativeFirst stated

Bringing forward validation to speed up the development of new active pharmaceutical ingredients

First written in FY2018-Q2. . Latest entry: FY2018-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Accelerating Development by Bringing Forward Validation of New Active Pharmaceutical Ingredient ProductsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2018-Q2First statedAnnual report

    「Bringing forward validation to accelerate the development of new active pharmaceutical ingredient products for pharmaceuticals」

    A measure to bring forward validation was reported for the first time, with the aim of accelerating the development of new products.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Mitani Sangyo's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.